Bracco Diagnostics has opened a new research center in Plan-Les-Ouates, an area on the outskirts of Geneva, Switzerland, where several new high-technology firms are sprouting up. The center will house Bracco Research, a unit of the company’s
Bracco Diagnostics has opened a new research center in Plan-Les-Ouates, an area on the outskirts of Geneva, Switzerland, where several new high-technology firms are sprouting up.
The center will house Bracco Research, a unit of the companys research and development division and Bracco Imaging, a new manufacturing plant. The plant will produce Braccos new ultrasound contrast agent, SonoVue.
The facility in Plan-Les-Ouates is part of the Milan-based companys research network, which includes advanced research centers in Milan and Princeton, NJ. Bracco will earmark a projected $95 million, or 190 billion lira, in 2000 for the new research and development center. Bracco also operates production centers in Milan and Ceriano Laghetto. Another new manufacturing plant will open soon in Torviscosa.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.